Industry News

• NIH funds eleven Research Centers in Minority Institutions  The NIMHD has funded three new awards and renewed the awards of eight institutions previously funded under the Research Centers in Minority Institutions Specialized Centers program.The centers will share $187 million over their five-year project periods, subject to available funds.
  August 23, 2019  
• Gilead and Galapagos complete closing of their transformative R&D collaboration  Gilead and Galapagos announced the closing of the global R&D collaboration agreement signed on July 14, 2019. The closing triggers an upfront license fee payment of $3.95 billion by Gilead to Galapagos. In addition, Gilead has made an equity investment in Galapagos of approximately $1.1 billion.
  August 23, 2019  
• Lilly announces top-line phase 3 results for oral JAK inhibitor baricitinib  Eli Lilly and Incyte announced that baricitinib met the primary endpoint in BREEZE-AD7, the third pivotal Phase 3 trial in the BREEZE-AD program to be completed in 2019. BREEZE-AD7, an investigational study evaluating efficacy and safety of baricitinib to treat moderate to severe AD.
  August 23, 2019  
• International team discovers unique pathway for treating deadly children’s brain cancer  An international team of researchers led by Yale University, University of Iowa, and TGen has discovered a new pathway that may improve success against an incurable type of children’s brain cancer. The study results were published in Nature Communications.
  August 23, 2019  
• Mosquitoes push northern limits with time-capsule eggs  Washington University research shows that invasive mosquitoes at the northern limit of their current range are surviving colder conditions than those in their native territory. Such local adaptation could have implications for efforts to control the species’ spread.
  August 23, 2019  
• Medtronic announces cash dividend for second quarter of 2020  The board of directors of Medtronic approved the FY 2020 second quarter cash dividend of $0.54 per ordinary share, representing an 8 percent increase over the prior year. Medtronic The dividend is payable Oct. 18, 2019, to shareholders of record at Sept. 27, 2019.
  August 23, 2019  
• UNMC scientists receive $650,000 for research in cancer, smoking diseases  Thirteen scientists at UNMC have received a cumulative $650,000 in grant funding to further their research in cancer and diseases related to smoking. Each research project is supported by a $50,000 grant from the Nebraska Cancer and Smoking Disease Research Program.
  August 23, 2019  
• Hemispherx Biopharma changes name to AIM ImmunoTech  Hemispherx Biopharma announced it has changed its name to AIM ImmunoTech effective September 3, 2019. Additionally, the Company announced the Company's ticker will change to "AIM." The Company's common stock will continue to trade on the NYSE American.
  August 23, 2019  
• Merck announces new data from leading lung cancer clinical development program  Merck announced new data from the company’s leading clinical development program in lung cancer. Key data in NSCLC)include new pooled findings from three trials – KEYNOTE-189, KEYNOTE-407 and KEYNOTE-021 - evaluating KEYTRUDA in combination with chemotherapy.
  August 22, 2019  
• AlloSure for heart transplant patients receives CMS draft coverage  CareDx announces AlloSure received a positive draft Local Coverage Determination for Medicare coverage in heart transplant patients. The Centers for Medicare and Medicaid Services released the draft version of the coverage policy issued by Palmetto GBA.
  August 22, 2019  

   (next 10 articles)